Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study (Q34413527)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study |
scientific article |
Statements
1 reference
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study (English)
1 reference
Jan van Lunzen
1 reference
Bonaventura Clotet
1 reference
Andrea Antinori
1 reference
Michael Saag
1 reference
Judith Feinberg
1 reference
Marie-Aude Khuong-Josses
1 reference
Irina Dumitru
1 reference
Vadim Pokrovskiy
1 reference
Jan Fehr
1 reference
Roberto Ortiz
1 reference
Julia Harris
1 reference
Clare Brennan
1 reference
Tamio Fujiwara
1 reference
Sherene Min
1 reference
ING114915 Study Team
1 reference
Identifiers
1 reference